Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
Collaboration streamlines patient access to oncology clinical trials
Subscribe To Our Newsletter & Stay Updated
